REFERENCE
Beard AJ.Examination of the cost-effectiveness of dopamine agonists for the treatment of restless legs syndrome. Value in Health 9: 81 (plus poster) abstr. PNL6, No. 3, May-Jun 2006
Rights and permissions
About this article
Cite this article
Ropinirole lacks dominance in restless legs syndrome. Pharmacoecon. Outcomes News 508, 4 (2006). https://doi.org/10.2165/00151234-200605080-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605080-00010